Search Results 1681-1690 of 12439 for Sertraline

1. A Study to Assess the MEK Inhibitor Mirdametinib (PD-0325901) in Patients with Neurofibromatosis Type 1 Associated Plexiform Neurofibromas - Mayo Clinic

   The purpose of this study is to evaluate PD-0325901 in the treatment of symptomatic inoperable neurofibromatosis type-1 (NF1)-associated plexiform neurofibromas ...

2. Patient Stories - Christopher J. McLeod, M.B., Ch.B., Ph.D. - Mayo Clinic

   Christopher J. McLeod, M.B., Ch.B., Ph.D. Cardiac Electrophysiologist. Request an Appointment.

3. Publications - Brian P. Shapiro, M.D., M.A. - Mayo Clinic

   Tayon Kevin, Carlisle Ashley, Taylor Bryan, Cornwell William, Shapiro Brian, Thomas Randal, Dineen Elizabeth. App-Timizing Cardiac Rehabilitation: Enhancing ...

4. Treatment of Pain Associated with Fibromyalgia - Mayo Clinic

   About this study. DS 5565 will be better than placebo (sugar pill without active drug) in managing fibromyalgia pain and will be well tolerated.

5. A Study to Assess the Efficacy and Safety of Risankizumab in Subjects With Moderately to Severely Active Crohn's Disease Who Failed Prior Biologic Treatment - Mayo Clinic

   The objective of Study M15-991 is to evaluate the efficacy and safety of risankizumab versus placebo during induction therapy in subjects with moderately to ...

6. Senolytic therapy eliminates senescent cells - Mayo Clinic

   With aging, senescent cells accumulate in the bone microenvironment where they promote osteoclastogenesis and inhibit osteoblastogenesis.

7. Ginseng as an Intervention to Decrease Cancer-Related Fatigue in Post-Treatment Cancer Survivors - Mayo Clinic

   Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

8. A Study to Learn About the Study Medicine (Elranatamab) in Participants With Multiple Myeloma That Has Come Back After Responding to Treatment or Has Not Responded to Treatment - Mayo Clinic

   About this study. The purpose of this study is to evaluate the safety of a step-up dosing approach (starting with low doses followed by higher doses) of the ...

9. A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of RO7303509 in Participants With Systemic Sclerosis - Mayo Clinic

   The purpose of this study is to evaluate the safety, tolerability, and pharmacokinetics of 12 weeks of RO7303509 treatment in patients with systemic sclerosis ( ...

10. De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA) - Mayo Clinic

    The purpose of this study is to evaluate whether breast conservation surgery and endocrine therapy results in a non-inferior rate of invasive or non-invasive ...